Validity and Reliability of the Turkish St. Marks Incontinence Score

• Sponsor: Atlas University (Other)
• Overall Status: Completed
• CT.gov ID: NCT05755763
• Collaborator: (none)
• Enrollment: 65
• Location: 1
• Actual Duration (Months): 1
• Patients Per Site Per Month: 63.8

Study Details

Study Description

Brief Summary

For the Turkish validity and reliability study of St.Mark's (Vaizey) Incontinence Score, which consists of 7 questions, it will be applied to 65 people diagnosed with anal incontinence after it is translated by translation-retranslation method.

Condition or Disease	Intervention/Treatment	Phase
Fecal Incontinence; Pelvic Floor Disorders	Other: Anal incontinence patients with St. Mark's Incontinence Score

Study Design

• Study Type: Observational
• Actual Enrollment: 65 participants
• Observational Model: Case-Control
• Time Perspective: Prospective
• Official Title: Validity and Reliability of the Turkish St. Marks Incontinence Score
• Actual Study Start Date: Feb 7, 2023
• Actual Primary Completion Date: Mar 8, 2023
• Actual Study Completion Date: Mar 10, 2023

Outcome Measures

Primary Outcome Measures

1. Turkish Validation an Reliability of St. Mark's Incontinence Score [1 month]

   St. Mark's Incontinence Score which shows the disease severity of anal incontinence patients and is used in the follow-up of their recovery status. The Turkish validity and reliability study of Mark's incontinence score will be conducted and it will be translated into Turkish.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• people with the complatint of anal incontinence

• being volunteered to participate

Exclusion Criteria:

• having difficulties in understanding and speaking Turkish

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Acibadem Atakent University Hospital	Istanbul		Turkey

Sponsors and Collaborators

• Atlas University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Yasemin Ecem Temel Pekmez, Principal Investigator, Atlas University
• ClinicalTrials.gov Identifier: NCT05755763
• Other Study ID Numbers: YETPekmez
• First Posted: Mar 6, 2023
• Last Update Posted: Mar 13, 2023
• Last Verified: Mar 1, 2023

• Individual Participant Data (IPD) Sharing Statement: Undecided
• Plan to Share IPD: Undecided
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Fecal Incontinence; Pelvic Floor Disorders

Study Results

No Results Posted as of Mar 13, 2023